SAU · 4007.SR · SAR
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 12:17 PM UTC. Cached market data; not a live quote.
One-year closing-price history · SAR. Historical prices are not a forecast.
Al Hammadi Holding Company’s quoted price sits in the lower half of its reported 52-week range, 38.81% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Al Hammadi Holding Company’s forward annual dividend is SAR 1.08 per share, paid quarterly. The forward yield is 5.04% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Al Hammadi Holding Company’s next earnings report is currently expected on Nov 10, 2026, with estimated earnings per share of SAR 0.37. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Al Hammadi Holding Company’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Established in Riyadh, Saudi Arabia, in 1985, Al Hammadi Holding Company specializes in the healthcare industry. Its core operations include the development, upkeep, and management of hospitals and medical centers across the Kingdom, primarily through its Medical Services and Pharmaceuticals Products divisions. Beyond direct healthcare provision, the company diversifies its business into the wholesale and retail distribution of medical equipment, pharmaceuticals, cosmetic products, and food and beverages. Al Hammadi also holds interests in real estate, acquiring and leasing land for construction, invests in various industrial ventures, and is involved in establishing and managing commercial centers. The company currently operates three healthcare facilities under the Al Hammadi Hospital brand, located in the Olaya, Suwaidi, and Al Nuzha districts of Riyadh.
Latest available per-share figures in SAR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 03:11 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q1 2025 | May 12, 2025 | SAR 0.46+9.52% vs estimate | SAR 302.00M+4.26% vs estimate |
|---|
| Q4 2024 | Mar 2, 2025 | SAR 0.49+4.26% vs estimate | SAR 323.00M+2.7% vs estimate |
|---|
| Q3 2024 | Nov 3, 2024 | SAR 0.400.0% vs estimate | SAR 291.00M+1.96% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
SAR 221.50-SAR 1.60 (-0.72%)
Dr. Sulaiman Al Habib Medical Services Group Company’s quoted price sits in the lower half of its reported 52-week range, 18.57% below the high.
SAR 55.20-SAR 0.40 (-0.72%)
Mouwasat Medical Services Company’s quoted price sits in the lower half of its reported 52-week range, 29.23% below the high.
SAR 64.95-SAR 0.65 (-0.99%)
Dallah Healthcare Company’s quoted price sits in the lower half of its reported 52-week range, 49.09% below the high.
SAR 30.32-SAR 0.06 (-0.2%)
Dr. Soliman Abdul Kader Fakeeh Hospital Co.’s quoted price sits in the lower half of its reported 52-week range, 29.23% below the high.
SAR 102.10+SAR 3.50 (+3.55%)
National Medical Care Company’s quoted price sits in the lower half of its reported 52-week range, 42.87% below the high.
SAR 12.97+SAR 0.27 (+2.13%)
Specialized Medical Company’s quoted price sits in the lower half of its reported 52-week range, 39.65% below the high.
SAR 23.65-SAR 0.43 (-1.79%)
Middle East Healthcare Company’s quoted price sits in the lower half of its reported 52-week range, 54.08% below the high.
SAR 1.19-SAR 0.02 (-1.65%)
Future Care Trading Co.’s quoted price sits in the lower half of its reported 52-week range, 51.63% below the high.
